Articles tagged with “eli-lilly”

Eli Lilly $3.8B Vaccine Acquisitions: Infectious Disease R&D

Examine Eli Lilly's $3.8B acquisition of three biotechs to build an infectious disease vaccine pipeline targeting shingles, EBV, and resistant bacteria.

35 min read

5/28/2026

eli lilly vaccine acquisitions infectious disease antimicrobial resistance shingles vaccine ebv vaccine pharma strategy biopharma pipeline

Pfizer Metsera Acquisition and GLP-1 Obesity Drug Market

Analyze Pfizer's $10B acquisition of Metsera and the evolving GLP-1 obesity drug market. Learn about competing pipelines, clinical data, and pharma strategy.

50 min read

5/2/2026

glp-1 agonists pfizer metsera acquisition obesity drugs pharmaceutical pipelines novo nordisk eli lilly pharma strategy weight loss medications

AI Biologics Design: Chai Discovery & Eli Lilly Partnership

Analyze the Chai Discovery and Eli Lilly partnership in AI biologics design. Examine how generative models like Chai-2 impact antibody drug development.

45 min read

4/17/2026

ai biologics design ai drug discovery chai discovery eli lilly generative ai antibody design protein engineering computational biology